Myriad Genetics | MYGN - 当期純利益





当期純利益 変化する 日付
Agilent USD 339M 34M 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Bruker USD 3.5M 22.5M 2026-03
Danaher USD 1.03B 168M 2026-03
Illumina USD 134M 200M 2026-03
J&J USD 5.24B 119M 2026-03
Mettler Toledo International USD 169.45M 116.31M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 251M 6M 2026-03
Quidel USD -91.8M 38.9M 2026-03
Repligen USD 8.33M 4.95M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Veracyte USD 28.71M 12.44M 2026-03
Waters USD -72M 297.21M 2026-03